TheProfitWatch

ENGN - enGene Holdings Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.9 -0.05 (-0.56%) --- --- --- --- -0.05 (-0.56%) 0.0 (0.0%) 0.0 (0.0%)

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
0.57
Diluted EPS:
0.57
Basic P/E:
15.5263
Diluted P/E:
15.5263
RSI(14) 1m:
71.43
VWAP:
8.81
RVol:

Events

Period Kind Movement Occurred At

Related News